![](/img/cover-not-exists.png)
TAS0728, a covalent-binding, HER2-selective kinase inhibitor shows potent antitumor activity in preclinical models
Irie, Hiroki, Ito, Kimihiro, Fujioka, Yayoi, Oguchi, Kei, Fujioka, Akio, Hashimoto, Akihiro, Ohsawa, Hirokazu, Tanaka, Kenji, Funabashi, Kaoru, Araki, Hikari, Kawai, Yuichi, Shimamura, Tadashi, WadhwaJournal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-18-1085
Date:
February, 2019
File:
PDF, 5.40 MB
2019